DOCSLIB.ORG

Early Warning and Response in Europe

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Early Warning and Response in Europe VOL.11 Issues 10-12 Oct-Dec 2006 EUROPEAN COMMUNICABLE DISEASE JOURNAL Early warning and response in Europe European regulation • Implementing the International Health Regulations (2005) in Europe Outbreak report • A pseudo-outbreak of human A/H5N1 infections in Greece Surveillance report • Improvement of a national public health surveillance system through quality circle FUNDED BY DG HEALTH AND CONSUMER PROTECTION OF THE COMMISSION OF THE EUROPEAN COMMUNITIES "Neither the European Commission nor any person acting on the behalf of the Commission is responsible for the use which might be made of the information in this journal. The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Commission, the European Centre for Disease Prevention and Control (ECDC), the Institut de veille sanitaire (InVS), the Health Protection Agency (HPA) or the institutions with which the authors are affiliated" Eurosurveillance VOL.11 Issues 10-12 Oct-Dec 2006 Peer-reviewed European information on communicable disease surveillance and control Articles published in Eurosurveillance are indexed by Medline/Index Medicus C ONTENTS E DITORIALS 202 • Measles elimination 2010 target: the need to meet the specific risk group 202 John S Spika • A/H5N1 in the European Union: current levels of risk to humans, and responding to human cases and outbreaks 203 Editorial offices Sarah De Martin, Angus Nicoll, Denis Coulombier France • From evaluation to continuous quality assurance Institut de Veille Sanitaire (InVS) 12, rue du Val d’Osne of surveillance systems 204 94415 Saint-Maurice, France Gérard Krause Tel + 33 (0) 1 41 79 68 33 Fax + 33 (0) 1 55 12 53 35 • Are there ‘new’ and ‘old’ ways to track infectious UK diseases hazards and outbreaks? 206 Health Protection Agency Jean-Claude Desenclos Centre for Infections 61 Colindale Avenue London NW9 5EQ, UK RIGINAL ARTICLES Tel + 44 (0) 20 8327 7417 O 208 Fax + 44 (0) 20 8200 7868 Topic: Early warning RESPONSIBLE EDITOR and response in Europe Gilles Brücker (InVS, France) • Implementing the International Health Regulations (2005) in Europe 208 MANAGING EDITORS G Rodier, M Hardiman, B Plotkin, B Ganter Hélène Therre (InVS, France) [email protected] • Epidemic intelligence: a new framework Elizabeth Hoile (HPA CfI, UK) for strengthening disease surveillance in Europe 212 [email protected] C Paquet, D Coulombier, R Kaiser, M Ciotti PROJECT LEADERS • The Early Warning and Response System for communicable Philippe Bossi (InVS, France) diseases in the EU: an overview from 1999 to 2005 215 Noel Gill (HPA CfI, UK)) P Guglielmetti, D Coulombier, G Thinus, F Van Loock, S Schreck ASSISTANT EDITORS • A national syndromic surveillance system for England Anneli Goldschmidt (InVS, France) and Wales using calls to a telephone helpline 220 [email protected] GE Smith, DL Cooper, P Loveridge, F Chinemana, Farida Mihoub (InVS, France) [email protected] E Gerard, N Verlander Candice Pettifer (ECDC, Sweden) • Syndromic surveillance based on emergency [email protected] department activity and crude mortality: two examples 225 L Josseran, J Nicolau, N Caillère, P Astagneau, G Brücker ASSOCIATE EDITORS Noel Gill (HPA CfI, UK) • Surveillance of ambulance dispatch data Stefania Salmaso (Istituto Superiore di Sanità, as a tool for early warning 229 Italy) KH Bork, BM Klein, K Mølbak, S Trautner, UB Pedersen, Henriette de Valk (InVS, France) E Heegaard Norman Noah (London School of Hygiene and Tropical Medicine, UK) • Enhanced Surveillance of Infectious Diseases : Richard Pebody (HPA CfI, UK) the 2006 FIFA World Cup experience, Germany 234 Kate Soldan (HPA CfI, UK) K Schenkel, C Williams, T Eckmanns, G Poggensee, Karl Ekdahl (ECDC, Sweden) J Benzler, J Josephsen, G Krause • Epidemiologic surveillance system implemented EDITORIAL ADVISORS in the Hautes-Alpes district, France, (see back cover) during the Winter Olympic Games, Torino 2006 239 F Franke, L Coulon, C Renaudat, B Euillot, N Kessalis, www.eurosurveillance.org P Malfait • Recognition of threats caused by infectious diseases © Eurosurveillance, 2006 in the Netherlands: the early warning committee 242 JC Rahamat-Langendoen, JA van Vliet, AWM Suijkerbuijk Eurosurveillance VOL.11 Issues 10-12 Oct-Dec 2006 S URVEILLANCE REPORTS 246 O UTBREAK DISPATCH 276 • Improvement of a national public health surveillance • Current outbreak of hepatitis A in Bulgaria, 2006 276 system through use of a quality circle 246 M Kojouharova, Editorial team G Krause, J Benzler, G Reiprich, R Görgen • Surveillance of influenza-like illness in England S HORT REPORTS 277 and Wales during 1966-2006 249 • Trichinella in pork: current knowledge on the suitability AJ Elliot, DM Fleming of freezing as a public health measure 277 • Respiratory viruses and influenza-like illness: E Pozio, CMO Kapel, AA Gajadhar, P Boireau, a survey in the area of Rome, winter 2004-2005 251 J Dupouy-Camet, HR Gamble G Rezza, C Valdarchi, S Puzelli, M Ciotti, F Farchi, • Impact of a genetic variant of Chlamydia trachomatis C Fabiani, L Calzoletti, I Donatelli, CF Perno on national detection rates in Sweden 278 • Using sentinel surveillance to monitor effectiveness of T Söderblom, A Blaxhult, H Fredlund, B Herrmann influenza vaccine is feasible: a pilot study in Denmark 254 A Mazick, AH Christiansen, S Samuelsson, K Mølbak O THER ONLINE- ONLY CONTENT 280 • Laboratory diagnosis of Lyme borreliosis at the Portuguese National Institute of Health (1990-2004) 257 N ATIONAL BULLETINS I Lopes de Carvalho, MS Núncio • Case-control study for risk factors for Q Fever in southwest England and Northern Ireland 260 HJ Orr, H Christensen, B Smyth, DAB Dance, D Carrington, Ian Paul, JM Stuart O UTBREAK REPORTS 263 • A pseudo-outbreak of human A/H5N1 infections in Greece and its public health implications 263 G Spala, T Panagiotopoulos, N Mavroidi, X Dedoukou, A Baka, P Tsonou, P Triantafyllou, A Mentis, V Kyriazopoulou, A Melidou, S Tsiodras • A measles outbreak in children under 15 months of age in La Rioja, Spain, 2005-2006 267 M Perucha, E Ramalle-Gómara, ME Lezaun, A Blanco, C Quiñones, M Blasco, MA González, C Cuesta, JE Echevarría, MM Mosquera, F de Ory • Outbreak of Salmonella enterica serotype Manhattan infection associated with meat products, France, 2005 270 H Noël, M Dominguez, FX Weill, A Brisabois, C Duchazeaubeneix, A Kerouanton, G Delmas, N Pihier, E Couturier • Investigation of a tuberculosis cluster at a job centre in Manchester, United Kingdom 273 A Kirkpatrick, C Bell, M Petrovic, M Woodhead, A Barrett, E Duffell, A Verma, F Reynolds The Eurosurveillance print edition is a compilation of weekly and monthly electronic releases published on the Eurosurveillance website. Only a representative selection of Eurosurveillance’s weekly release articles from each three month period are printed here, and the full listing of all Eurosurveillance articles can be found in the Archives section of the website. E DITORIAL M EASLES ELIMINATION 2010 TARGET: THE NEED TO MEET THE SPECIFIC RISK GROUP John S Spika WHO Regional Office for Europe, Copenhagen, Denmark Substantial progress has been made within the World Health may have received none or only one dose of measles vaccine, yet Organization European Region in recent years towards the measles they have not been exposed to measles because virus circulation has and rubella elimination targets for 2010. These 2010 targets were diminished with vaccine use. Ensuring that all healthcare workers set in 2005 by the WHO European Regional Office for Europe, are adequately protected is key to preventing healthcare-associated following the approval of the Resolution EUR/RC55/R7 [1,2]. In infections. Immunisation records of healthcare workers should be 2005, 28 (54%) of 52 WHO member states reviewed and careful consideration given to reported a measles incidence of < 1 per million The ability to epidemiologically ensuring that all have received two doses of population (one indicator for measuring measles measles vaccine, unless they were born well elimination status) and by 2006, 50 (96%) had and virologically link measles cases before measles vaccine was introduced. introduced rubella vaccine into their national with a source is critical for assessing The high proportion of measles cases programmes. In 2002, member states began observed in children aged 15 months or younger reporting measles cases by age and vaccination the interruption of endemic is noteworthy, given this is younger than the status to WHO on a monthly basis [3] and case- transmission within and between recommended age in La Rioja for the first dose based reporting was implemented in 2003. of measles vaccine. The most effective primary Since that time, the number of countries countries in the European Region. prevention strategies for measles among those reporting case-based data has increased from younger than the age of first dose are to ensure one in 2003 to 23 in 2006. In 2006, countries have been asked high levels of immunity among older siblings and caregivers. to report rubella cases monthly (either aggregate or case-based). Outbreaks such as the one in La Rioja require that public health The WHO European Region measles/rubella laboratory network has officials develop interventions customised to meet the specific risk also been strengthened through regular laboratory assessments and group based on a thorough epidemiological investigation. Once the proficiency testing and by having subregional meetings. decision has been taken to immunise infants at an age younger The past two years have been challenging, with several large than the routine first dose, it is also necessary to decide when the outbreaks in the European Region. The outbreaks in Romania and practice should be discontinued. Outbreaks such as this could the Ukraine [4] were the source of measles outbreaks in a number justify the decision for countries where the first dose of measles of EU countries, including Estonia, Germany, Lithuania, Portugal, vaccine is currently given at 12 months not to further postpone Poland and Spain.
Load more

Recommended publications
  • November 2016 NEMSN Newsletter
    Vol. Vol. 26 No.No. 1 1 The National Eosinophilia-Myalgia Syndrome Network, Inc. November Page 2016 1 Friends Supporting Friends National EMS Network NEMSN National Eosinophilia-Myalgia Syndrome Network, Inc. http:www.nemsn.org Newsletter Points of interest ………………..……………... NEMSN is extremely pleased to announce that Stephen Naylor, • Your continued do- Ph.D. has joined our Medical Advisory Panel as NEMSN's nations have kept Science Advisor. Welcome, Dr. Naylor. this Newsletter and NEMSN alive. Dr. Stephen Naylor is one of only a handful of distin- Please keep those guished scientists who have devoted years of research in donations coming an attempt to achieve a complete explanation of EMS. no matter how Known as a chemist, biochemist, toxicologist and business large or small. Our originator, he has co-authored hundreds of scientific re- thanks. search papers and book chapters while delivering un- ………………………………….. counted presentations at universities and medical centers • We are interested worldwide. In the 1990s he and NEMSN advisor Gerald J. in your story. Please Gleich, M.D. partnered at the Mayo Clinic in Rochester, take the time to MN to undertake definitive EMS and L-tryptophan re- write it and send to search. Naylor and Gleich received NIH and WHO grants us for our newslet- and co-authored a number of scholarly papers during that period. ter. …………………………………... Stephen Naylor received his Ph.D. from the University of Cambridge (UK) in Biochem- • If you have not seen istry. He completed postdoctoral work at the Massachusetts Institute of Technology our web site yet, it where he later became a visiting faculty member in the Division of Biological Engineer- is very informative.
    [Show full text]
  • The Compelling Facts About Plastics an Analysis of Plastics Production, Demand and Recovery for 2005 in Europe - Published Spring 2007
    The Compelling Facts About Plastics An analysis of plastics production, demand and recovery for 2005 in Europe - Published Spring 2007 Contents 2005 at a glance 3 Plastics today – a global success story 4 Production and market demand of plastics in a world context 6 Production and demand in EU25+N/CH 7 Key figures 8 Plastics in a resource efficiency perspective 0 The plastics supply chain from cradle to grave Plastics continue to decouple growth in demand and material to landfill 2 Resource management strategies vary across Europe 3 Trends in mechanical recycling 4 Trends in feedstock recycling 6 Trends in energy recovery 7 Used plastics by sector 8 What has Europe learned, and what about the future? 9 References 20 What has changed? This brochure on production, demand and recovery in 2005 is the sixteenth annual publication by the manufacturers of plastics raw materials in Europe It aims to provide both an overview of the development of plastics in their wide variety of applications and the progress made to recover these plastics at their end- of-life phase PlasticsEurope’s Market Research and Statistics Group provided the input on production and demand of the plastics raw materials Consultic GmbH collected and estimated waste generation and recovery data for EU25+N/CH* For recovery data, official statistics have been used whenever these have been available from European or National authorities and waste management companies or organisations Where required research or knowhow from consultants has been used to complete the picture The
    [Show full text]
  • (Pasr) Bio 3R Project “Bioterrorism Resilience, Research, Reaction”
    BIO3R Supporting Activity Title: Scenario Launching Report Id: <BIO3R reference> Version: 1.0 PREPARATORY ACTION IN SECURITY AND RESEEARCH (PASR) BIO 3R PROJECT “BIOTERRORISM RESILIENCE, RESEARCH, REACTION” OPERATIONAL REQUIREMENTS 1.1 GENERAL OPERATIONAL REQUIREMENTS The issues discussed hereafter are concerning the global response to BioT crises. They are relevant for all nine scenarios. 1.1.1 Crisis management at the national level Perception of the BioT risk in the different MSs The organisation of response to BioT events varies significantly between the MSs. Differences related to the political history, the economic development, or demography and geography could probably be addressed in a specific study. Major differences in the level of preparedness are also observed between SMs with similar economical, demographic and geographical constraints. The best prepared MSs have developed comprehensive global BioT plans, while others have only BioT plans restricted for example to protocols for the treatment of suspect parcels. It appears that the perception of the BioT risk differs significantly from one MS to another. The rationale for these differences is unclear. It deserves further analysis, as the harmonization and coordination of the response at the European level requires a consensus among MSs about the priorities in health security. “Natural” resilience of Public Health System The lack of global BioT emergency plans does not necessarily means that resilience will be low in any case. The general robustness of European medical care systems together with the plans already existing or specifically developed for the response to “naturally” occurring outbreaks or major national incident or international cooperation in major crisis may provide efficient response to several scenarios.
    [Show full text]
  • Neuropathology Category Code List
    Neuropathology Page 1 of 27 Neuropathology Major Category Code Headings Revised 10/2018 1 General neuroanatomy, pathology, and staining 65000 2 Developmental neuropathology, NOS 65400 3 Epilepsy 66230 4 Vascular disorders 66300 5 Trauma 66600 6 Infectious/inflammatory disease 66750 7 Demyelinating diseases 67200 8 Complications of systemic disorders 67300 9 Aging and neurodegenerative diseases 68000 10 Prion diseases 68400 11 Neoplasms 68500 12 Skeletal Muscle 69500 13 Peripheral Nerve 69800 14 Ophthalmic pathology 69910 Neuropathology Page 2 of 27 Neuropathology 1 General neuroanatomy, pathology, and staining 65000 A Neuroanatomy, NOS 65010 1 Neocortex 65011 2 White matter 65012 3 Entorhinal cortex/hippocampus 65013 4 Deep (basal) nuclei 65014 5 Brain stem 65015 6 Cerebellum 65016 7 Spinal cord 65017 8 Pituitary 65018 9 Pineal 65019 10 Tracts 65020 11 Vascular supply 65021 12 Notochord 65022 B Cell types 65030 1 Neurons 65031 2 Astrocytes 65032 3 Oligodendroglia 65033 4 Ependyma 65034 5 Microglia and mononuclear cells 65035 6 Choroid plexus 65036 7 Meninges 65037 8 Blood vessels 65038 C Cerebrospinal fluid 65045 D Pathologic responses in neurons and axons 65050 1 Axonal degeneration/spheroid/reaction 65051 2 Central chromatolysis 65052 3 Tract degeneration 65053 4 Swollen/ballooned neurons 65054 5 Trans-synaptic neuronal degeneration 65055 6 Olivary hypertrophy 65056 7 Acute ischemic (hypoxic) cell change 65057 8 Apoptosis 65058 9 Protein aggregation 65059 10 Protein degradation/ubiquitin pathway 65060 E Neuronal nuclear inclusions 65100
    [Show full text]
  • (2005) I N Europe
    O RIGINAL ARTICLES Surveillance report I MPLEMENTING THE INTERNATIONAL HEALTH REGULATIONS (2005) IN EUROPE G Rodier1, M Hardiman1, B Plotkin1, B Ganter2 The adoption of the International Health Regulations (2005) (also of Member States of the WHO Regional Office for Europe in June referred to as IHR(2005) or the revised Regulations) provides a 2004, as well as a large number of written comments submitted to remarkable new legal tool for the protection of international public WHO. Under the new IHR(2005), WHO Member States have until health. Upon entry into force on 15 June 2007, Article 2 (‘Purpose 15 December 2006 to officially notify the WHO Director General of and scope’) provides that the overall focus of the efforts of States rejection of, or reservations about the IHR(2005), or they will become Parties (and World Health Organization’s efforts under the revised bound by the revised Regulations on 15 June 2007. Regulations will be to prevent, protect against, control and provide a Although the IHR(2005) build in part upon the text of current public health response to the international spread of disease in ways IHR(1969)[2], they are primarily based on the most recent experiences that are commensurate with the public health risks and which avoid of WHO and Member States in national surveillance systems, unnecessary interference with international traffic. Health measures epidemic intelligence, verification, risk assessment, outbreak alert, under the revised Regulations will be implemented with respect for and coordination of international response, all of which are part of travellers’ human rights, with several specific new requirements in this WHO’s ongoing work on global health security [3].
    [Show full text]
  • A Scoping Study of Emergency Planning and Management in Health Care: What Further Research Is Needed?
    National Institute for Health Research Service Delivery and Organisation Programme A scoping study of emergency planning and management in health care: What further research is needed? Alan Boyd,1 Naomi Chambers,1 Simon French,1 Russell King,2 Duncan Shaw,3 and Alison Whitehead4 1 Manchester Business School 2 Royal Free London NHS Foundation Trust 3 Aston University Business School 4 Wrightington, Wigan and Leigh NHS Foundation Trust Published July 2012 This project is funded by the Service Delivery and Organisation Programme Address for correspondence: Alan Boyd Manchester Business School Booth Street West Manchester M15 6PB Email: [email protected] This report should be referenced as follows: Boyd A, Chambers N, French S, King RA, Shaw D, Whitehead AS. A scoping study of emergency planning and management in health care: What further research is needed? Final report. NIHR Health Services and Delivery Research programme; 2012. Relationship statement: This document is an output from a research project that was funded by the NIHR Service Delivery and Organisation (SDO) programme based at the National Institute for Health Research Evaluations, Trials and Studies Coordinating Centre (NETSCC) at the University of Southampton. The management of the project and subsequent editorial review of the final report was undertaken by the NIHR Service Delivery and Organisation (SDO) programme. From January 2012, the NIHR SDO programme merged with the NIHR Health Services Research (NIHR HSR) programme to establish the new NIHR Health Services and Delivery Research (NIHR HS&DR) programme. Should you have any queries please contact [email protected]. Copyright information: This report may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising.
    [Show full text]
  • Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19
    Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Centers for Disease Control Stephen B Thackery, David J Sencery, and Harold W Jaffe, Centers for Disease Control and Prevention, Atlanta, GA, USA Ó 2017 Elsevier Inc. All rights reserved. This article is an updated version of the previous edition article by Stephen B. Thacker, David J. Sencer, volume 1, pp. 549–555, Ó 2008, Elsevier Inc. Early History of the Centers for Disease Control Health Officials and the American Public Health Association and Prevention agreed that CDC take the lead in defining what diseases were of highest priority and should be reportable. The key The history of the Centers for Disease Control and Prevention figure in this expansion of the CDC role was Alexander D. (CDC) began in 1942 with the establishment of the Malaria Langmuir, MD (1910–93), who was brought to the CDC in Control in War Areas (MCWA), under the U.S.
    [Show full text]
  • ECDC Insight Is a Newsletter Published by the European Cen- Tre for Disease Prevention and Control (ECDC), Stockholm
    Insight www.ecdc.europa.eu Minister Ulla Schmidt & Director Zsuzsanna Jakab In this issue: present ECDC’s first report on communicable disease 1. Minister Ulla Schmidt epidemiology in the EU & Director Zsuzsanna Jakab present On 7 June 2007 Minister Ulla Schmidt, ropean data sets in order to maximise ECDC’s first report Germany’s Federal Minister for Health, the return on investment made by the on communicable and ECDC’s Director Zsuzsanna Jakab Member States and EU institutions. The disease epidemiology presented the first ever comprehensive report notes that important challenges in the EU report on the multiple threats posed by remain relating to disease surveillance. communicable diseases in the EU. The 2. Editorial by Director event took place at the European Cen- Zsuzsanna Jakab tre for Disease Prevention and Control (ECDC) in Stockholm and was organised Chikungunya fever: in partnership with the European Com- ECDC-led team visits mission and the German Presidency Italy of the EU. The report contains a large volume of epidemiological data on 49 ECDC external communicable diseases (together with evaluation launched healthcare-associated infections and antimicrobial resistance) collected from 3. Four European 25 Member States, Norway and Iceland networks’ for 2005. coordination activities to be The incidence of most of the diseases managed at ECDC looked at in the report has either fallen From right to left: German’s Health Minister Ulla Schmidt, or remained stable over the past decade. ECDC Director Zsuzsanna Jakab, Head of Health Threat Unit Evaluation and Not all the trends are positive though. John F. Ryan (EC, DG Sanco) and Ben Duncan (ECDC) assessment of EU- For example, incidence of campylobacter wide surveillance has risen in recent years.
    [Show full text]
  • Global Population Ageing, Migration and European External Policies
    Various studies on the policy implications of demographic change in national and Community policies LOT 5 Global Population Ageing, Migration and European External Policies Final report Contract VC/2005/0637 November 2006 Bo Malmberg Institute for Futures Studies Stockholm Sweden 1 Team of experts Bo Malmberg Kristof Tamas David Bloom Rainer Munz David Canning 2 © Institutet för Framtidsstudier, 2006 ISBN [Klicka här och skriv ISBN nr] ISBN [Klicka här och skriv ISBN nr] Textbearbetning och produktion: [Klicka här och skriv] Omslag: Carlsson/Neppelberg Tryck: [Klicka här och skriv] Distribution: Institutet för Framtidsstudier 3 Executive Summary During the last decades, it has become increasingly clear that demographic change constitutes one of the most important challenges of the 21st century. One important factor that has placed demographic change high on the political agenda is an increasing awareness of current demographic trends. Another factor that has contributed to the growing interest in demography is an emerging consensus among social scientists that demographic change is a vital trigger for social, economic and political development. The main question in this report is to what extent European external policies should be reconsidered in the light of current demographic challenges. The report is divided into three parts. In the first, introductory part, we take a look at current demographic trends. In the second part, we analyze demographic transitions and their economic, social and geo-political implications. In the third part of the report, European migration policies are in focus. The following points summarize the main findings. Some basic facts 1) Global population, which stood at 2.5 billion in 1950, has risen to 6.6 billion today.
    [Show full text]
  • Transmission of Pathogens and Molecular Phylogenetics
    WHO collaborating centre for Arbovirus and Hemorrhagic Fever Reference and Research Transmission of pathogens and molecular phylogenetics: From surveillance typing to metagenomics Prof Dr Marion Koopmans, public health virology [email protected]; eLibrary @MarionKoopmans © by author ESCMID eLibrary © by author Research focus: getting ahead of the curve ESCMIDKaresh et al., 2012 eLibrary © by author EID: the challenge . Most EID come from animals, . Once introduced in people, many but prediction of transmissibility opportunities for transmission: and severity are challenging . WHEN it occurs, things can move extremely fast ESCMIDWolfe et al., 2007; http://rambaut.github.io/EBOV_Visualization/Makona_1561_D3/; eLibrary Gytis et al., 2017 © by author Perspective: The use of pathogen genetic data that can inform (emerging) disease preparedness and response . What pathogens to track and how to do that efficiently? . role of metagenomics? . From genotype to phenotype: prediction of key parameters for hazard characterisation / decision making . Ability to infect humans and transmit between them . Ability to cause (severe) disease . Treatability . TrackingESCMID of sources and transmission eLibrary pathways © by author Choice of method and necessary resolution depends on question asked ICTV, increasingly uniform Family . Caliciviridae Genus . Norovirus (vesi-, sapo, ea) diagnosis tracking outbreak Species . Genogroup I, II, III, IV, V, VI, VII X Subgroup . Genotype GII.4, 40 genotypes (X) … . GII4: antigenic variant Sydney X … . Sequence type, SNP’s X X Specialists > Wide ESCMID diversity eLibrary © by author Choice of method and necessary resolution depends on question asked Family . Orthomyxoviridae Genus . Influenza A - Toghoto diagnosis tracking outbreak Species . Influenza A virus X Subgroup . Subtypes HA and NA X … . antigenic variants, host variants X X X … .
    [Show full text]
  • Toxic Oil Syndrome
    The WHO Regional OILSYNDROME TOXIC Offi ce for Europe The World Health Organization (WHO) is a specialized agency of the United Nations This is the third book published by WHO on the outbreak created in 1948 with the of the condition that came to be called the toxic oil primary responsibility for international syndrome (TOS), which struck Spain in 1981. It killed health matters and public health. The several hundred people and affected more than 20 000, WHO Regional Offi ce many of whom remain ill today. The two previous books for Europe is one of six regional offi ces described, respectively, early observations and scientifi c throughout the world, each with its own fi ndings gathered throughout the 1980s. programme geared to the particular health conditions of the This volume refl ects the progress made in the last ten countries it serves. years under a carefully planned strategy undertaken on Member States Albania | four main fronts by the WHO/CISAT Scientifi c Committee TENYEARS OF PROGRESS Andorra for the Toxic Oil Syndrome. First, various projects were Armenia supported aiming at the full chemical characterization Austria Azerbaijan of the oil matrix. Second, attempts were made to Belarus reproduce, on both a laboratory and an industrial scale, Belgium Bosnia and Herzegovina the refi ning process to which the suspect oil had been Bulgaria subjected in an attempt to establish the conditions Croatia Cyprus under which the toxin(s) were generated and to provide Czech Republic Denmark suffi cient amounts of reconstituted oils for toxicological Estonia studies. Third, a search was undertaken for an animal Finland France model in which to study the disease.
    [Show full text]
  • Chapter 4 Prevention of Trichinella Infection in the Domestic
    FAO/WHO/OIE Guidelines for the surveillance, management, prevention and control of trichinellosis Editors J. Dupouy-Camet & K.D. Murrell Published by: Food and Agriculture Organization of the United Nations (FAO) World Health Organization (WHO) World Organisation for Animal Health (OIE) The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations, of the World Health Organization and of the World Organisation for Animal Health concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The designations 'developed' and 'developing' economies are intended for statistical convenience and do not necessarily express a judgement about the stage reached by a particular country, territory or area in the development process. The views expressed herein are those of the authors and do not necessarily represent those of the Food and Agriculture Organization of the United Nations, of the World Health Organization and of the World Organisation for Animal Health. All the publications of the World Organisation for Animal Health (OIE) are protected by international copyright law. Extracts may be copied, reproduced, translated, adapted or published in journals, documents, books, electronic media and any other medium destined for the public, for information, educational or commercial purposes, provided prior written permission has been granted by the OIE. The views expressed in signed articles are solely the responsibility of the authors. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these have been endorsed or recommended by FAO, WHO or OIE in preference to others of a similar nature that are not mentioned.
    [Show full text]